G

Gene+ Tech Stack

Precision oncology and genomic profiling for cancer patient treatment matching

Biotechnology Research Beijing 1,001–5,000 employees Founded 2015 Privately Held

Gene+ operates a clinical-stage genomics business anchored in next-generation sequencing (NGS) assays and cancer genomic interpretation. The tech stack—Python, R, GATK, PyTorch, TensorFlow, plus LIMS and bioinformatics tools (Scanpy, Seurat)—reflects a research-first, analysis-heavy organization. Active adoption of RAG signals a shift toward AI-powered interpretation of genomic data. Hiring is sales-dominated (28 of 54 roles) with decelerating velocity, suggesting a pivot from product build toward revenue expansion and market access in China.

Tech Stack 16 technologies

Core StackLinux Python PyTorch TensorFlow PowerPoint Perl R C Bash GATK LIMS Scanpy Seurat Dify Coze

AdoptingRAG

What Gene+ Is Building

◆Challenges

Meeting inpatient targets
Increasing inpatient admissions
Achieving inpatient targets
Reducing overdue receivables
Patient recruitment for clinical trials
Ngs workflow automation
Product competitiveness
Expanding pharma collaborations
Securing government subsidies
Obtaining government approvals

▲Active Projects

Clinical new indicator application research project
Pathogen detection product development
Government research project applications
Internal bioinformatics tools
Clinical database build and maintenance
Ai intelligent agent development
Lims system upgrade and optimization
Business sop optimization and system launch
Virtual gene perturbation module
Clinical trial patient recruitment

Hiring Activity

Decelerating55 roles · 15 in 30d

Department

Sales

28

Research

7

Data

5

Product

5

Engineering

3

Healthcare

2

Ops

2

Legal

1

Seniority

Intern

19

Mid

19

Manager

10

Senior

5

Junior

1

Company intelligence

Find more companies like Gene+ by tech stack, pain points and active projects

Get started free

About Gene+

Founded in 2015, Gene+ provides comprehensive genomic profiling and cancer precision medicine services to hospitals, biopharmas, and research institutions. The company operates CAP-, EMQN-, and ISO-accredited clinical laboratories and has processed over 400,000 samples. Core offerings include NGS-based assays that identify cancer mutations and recommend targeted therapies, immunotherapies, and clinical trial matches via automated bioinformatic analysis. The company maintains active research partnerships with academic centers (MD Anderson, Duke) and pharmaceutical firms (BeiGene, AstraZeneca), with over 400 collaborative projects and 230+ peer-reviewed publications. Operations are based in Beijing and serve primarily the Chinese market.

HeadquartersBeijing

Company Size1,001–5,000 employees

Founded2015

Hiring MarketsChina

Frequently Asked Questions

What is Gene+ tech stack?

Gene+ uses Python, R, Perl, C, and Bash for bioinformatics pipelines, plus GATK for variant calling and PyTorch/TensorFlow for machine learning. Analysis tools include LIMS, Scanpy, and Seurat for single-cell genomics. The company is adopting RAG for enhanced data interpretation.

What countries does Gene+ operate in?

Gene+ is headquartered in Beijing, China, and all hiring is currently in China. The company serves domestic hospitals and research institutions, with international partnerships in research and publishing.